- Home
- HCWB vs NAAS Comparison
HCWB vs NAAS Comparison
Compare HCWB & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- NAAS
- Stock Information
- Founded
- HCWB 2018
- NAAS 2019
- Country
- HCWB United States
- NAAS China
- Employees
- HCWB N/A
- NAAS N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- HCWB Health Care
- NAAS Consumer Discretionary
- Exchange
- HCWB Nasdaq
- NAAS Nasdaq
- Market Cap
- HCWB 8.4M
- NAAS 9.0M
- IPO Year
- HCWB 2021
- NAAS 2017
- Fundamental
- Price
- HCWB $3.00
- NAAS $3.76
- Analyst Decision
- HCWB Strong Buy
- NAAS
- Analyst Count
- HCWB 1
- NAAS 0
- Target Price
- HCWB $35.00
- NAAS N/A
- AVG Volume (30 Days)
- HCWB 121.2K
- NAAS 12.0K
- Earning Date
- HCWB 11-14-2025
- NAAS 10-24-2025
- Dividend Yield
- HCWB N/A
- NAAS N/A
- EPS Growth
- HCWB N/A
- NAAS N/A
- EPS
- HCWB N/A
- NAAS N/A
- Revenue
- HCWB $422,026.00
- NAAS $21,817,052.00
- Revenue This Year
- HCWB $178.64
- NAAS $378.49
- Revenue Next Year
- HCWB N/A
- NAAS N/A
- P/E Ratio
- HCWB N/A
- NAAS N/A
- Revenue Growth
- HCWB N/A
- NAAS N/A
- 52 Week Low
- HCWB $2.30
- NAAS $1.96
- 52 Week High
- HCWB $100.80
- NAAS $55.84
- Technical
- Relative Strength Index (RSI)
- HCWB 41.44
- NAAS 58.59
- Support Level
- HCWB $2.30
- NAAS $3.43
- Resistance Level
- HCWB $3.78
- NAAS $3.72
- Average True Range (ATR)
- HCWB 0.37
- NAAS 0.25
- MACD
- HCWB -0.05
- NAAS 0.03
- Stochastic Oscillator
- HCWB 49.38
- NAAS 100.00
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.